IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MEI Pharma, Inc.

CUSIP: 57232I303 | 1 institutional holders

Quarters

Q4 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2013

Aisling Capital LLC770,000
3.8% of portfolio›$6.2K
StyleTurnoverLocationFiled
Aisling Capital LLC
770,000$6.2K3.8%N/AN/ANew York, NY2014-02-13